Furthermore, in a study published soon afterward (Skinnider et al., 2001), it was shown that most CHL patients exhibited expression of IL-13, whereas this trait was either observed in none or fewer than 50% of patients with other forms of lymphoma, such as DLBCL. Here, IL13 is linked to diffuse large B-cell lymphoma.